Mangalam Drugs and Organics Cash Flow
- Market cap
- ₹50.65 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹23.04 – ₹43.20
In the year ended FY25, Mangalam Drugs and Organics generated ₹3.04 crore from operating activities, invested ₹2.03 crore and paid out ₹0.76 crore on financing activities. Net cash flow for the year was ₹0.25 crore. Free cash flow was ₹1.27 crore.
Mangalam Drugs and Organics cash flow statement
Financial years, newest first. Negative figures are cash outflows.
| Item | FY25 |
|---|---|
| Cash from operating activities | 3.04 |
| Cash from investing activities | -2.03 |
| Cash from financing activities | -0.76 |
| Net cash flow | 0.25 |
| Capital expenditure | 1.77 |
| Free cash flow | 1.27 |
Source: Company filings, in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Mangalam Drugs and Organics cash flow — frequently asked questions
What is Mangalam Drugs and Organics' operating cash flow?
Mangalam Drugs and Organics' cash flow from operating activities was ₹3.04 crore in the year ended FY25.
What is Mangalam Drugs and Organics' free cash flow?
Mangalam Drugs and Organics' free cash flow — operating cash flow minus capital expenditure — was ₹1.27 crore in FY25, after capital expenditure of ₹1.77 crore.
How much did Mangalam Drugs and Organics spend on investing activities?
Net cash used in investing activities was ₹2.03 crore in FY25. This covers capital expenditure, acquisitions and the purchase or sale of investments.
Same Data For Peers
Trade Mangalam Drugs and Organics With ATS
Track MANGALAM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.